Know Cancer

or
forgot password
  • cancer clinical trials in dallas, TX

  • Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Cervical Cancer
    Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
    Medical City Dallas Hospital
    Dallas, Texas 75230
    Lymphoma, Lymphoproliferative Disorder
    Safety Study of PLX108-01 in Patients With Solid Tumors
    Texas Oncology, PA (North)
    Dallas, Texas 75246
    At This Time, All Cohorts Are Closed to Enrollment With the Exception of the Pigmented Villo-nodular Synovitis (PVNS) Cohort.
    Reduced Intensity Transplant Conditioning Regimen for Severe Thalassemia
    Ut Southwestern Medical Center
    Dallas, Texas 75390
    Severe Thalassemia
    Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL)
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Refractory Cutaneous T-cell Lymphoma
    Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
    Texas Oncology, P.A. Presbyterian Hospital (2)

    Trial Locations
    Texas Oncology, P.A. Presbyterian Hospital (2)
    Texas Oncology, P.A. Midtown
    Texas Oncology, P.A. Texas Oncology - Sammons
    Texas Cancer Center ( Medical City Dallas Hospital) Dept. of Texas Cancer Ctr. (2)
    Texas Oncology, P.A. Texas Onc - Amarillo
    University of Texas Southwestern Medical Center University of TX SW Med Ctr(2)
    HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer
    LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
    1199.15.10108 Boehringer Ingelheim Investigational Site
    Dallas, Texas
    Ovarian Neoplasms, Peritoneal Neoplasms
    Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
    Mary Crowley Cancer Research Center
    Dallas, Texas 75246
    Refractory Head and Neck Cancer, Squamous Cell Carcinoma, Skin, Carcinoma of the Breast, Malignant Melanoma
    Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes
    ImClone Investigational Site
    Dallas, Texas 75230
    Cancer, Solid Tumor
    Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
    Sammons Cancer Center
    Dallas, Texas
    Pancreatic Cancer, Ductal Adrenocarcinoma, Exocrine Pancreatic Cancer
    Stereotactic Body Radiation Therapy With or Without Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Pancreatic Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    University of Texas Southwestern Medical Center
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
    Ut Southwestern Medical Center
    Dallas, Texas 75390
    Non Small Cell Lung Cancer
    Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.
    Methodist Charlton Cancer Center Methodist

    Trial Locations
    Methodist Charlton Cancer Center Methodist
    University of Texas Southwestern Medical Center DeptofSimmons Cancer Center(3)
    Carcinoma
    A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer
    Location #26

    Trial Locations
    Location #26
    Location #30
    Metastatic Breast Cancer
    Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
    University of Texas, Southwestern Medical Center
    Dallas, Texas 75390
    Breast Neoplasms, Breast Cancer, Breast Tumors
    Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas

    Trial Locations
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Parkland Memorial Hospital
    Ovarian Cancer
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation
    University of Texas Southwestern Medical Center UTSW Medical Center
    Dallas, Texas 75390-8527
    Relapsed or Refractory Multiple Myeloma
    Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Survey of Inhibitors in Plasma-Product Exposed Toddlers
    Children's Medical Center, Center for Cancer and Blood Disorders
    Dallas, Texas 75235
    Hemophilia A
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Pancreatic Cancer
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Texas Oncology

    Trial Locations
    Texas Oncology
    Texas Oncology Medical City Dallas
    Texas Oncology-Methodist Charlton Cancer Center
    Texas Oncology-Dallas Presbyterian Hospital
    Metastatic Breast Cancer
    Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
    Baylor University Medical Center, Blood & Marrow Transplant Center
    Dallas, Texas 75246
    Relapsed Multiple Myeloma
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas

    Trial Locations
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Parkland Memorial Hospital
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    US Oncology -Texas Oncology, PA - Dallas
    Dallas, Texas 75231
    Multiple Myeloma
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Parkland Memorial Hospital

    Trial Locations
    Parkland Memorial Hospital
    University of Texas Southwestern Medical Center
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    Medical City Dallas Hospital
    Dallas, Texas 75230
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
    UTsouthwestern medical center
    Dallas, Texas 75390
    Malignant Pleural Mesothelioma
    Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Multiple Myeloma
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    UT Southwestern
    Dallas, Texas 75390
    Peripheral T-cell Lymphoma
    Triple Negative Breast Cancer Biomarker Study
    Texas Oncology-Dallas Presbyterian Hospital

    Trial Locations
    Texas Oncology-Dallas Presbyterian Hospital
    Texas Oncology-Baylor Charles A. Sammons Cancer Center
    Metastatic Breast Cancer, Triple Negative Breast Cancer